(Q37233527)

19 August 2017

False resistance to imipenem with a microdilution susceptibility testing system (English)

1 reference

19 August 2017

O'Rourke EJ

1

1 reference

19 August 2017

Lambert KG

2

1 reference

19 August 2017

Parsonnet KC

3

1 reference

19 August 2017

Macone AB

4

1 reference

19 August 2017

Goldmann DA

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 April 1991

1 reference

Journal of Clinical Microbiology

19 August 2017

1 reference

19 August 2017

29

1 reference

19 August 2017

4

1 reference

19 August 2017

827-829

1 reference

Imipenem susceptibility testing with a commercially prepared dry-format microdilution tray.

19 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269881

Bioactivity of imipenem as a function of medium, time, and temperature

6 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=269881

Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid

26 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1909714

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Determination of imipenem (N-formimidoyl thienamycin) in human plasma and urine by high-performance liquid chromatography, comparison with microbiological methodology and stability

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1909714

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

19 August 2017

PubMed publication ID

1909714

1 reference